Hebrew Site 

 

11/12/2001- Pharmos Compounds Demonstrate Neuroprotection in Stroke and Parkinson's Disease Models 11/06/2001- Pharmos Reports 2001 Third Quarter and Nine Month Results 10/10/2001- Pharmos Corporation Sells Ophthalmic Products to Bausch & Lomb Proceeds to Fund Core CNS and Neuro-Inflammatory Business Could Reach $49 Million

 

More News:

<<Recent News >>         << 2003 News >>         << 2002 News >>